mantle cell lymphoma
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
mantle cell lymphoma
Aug 25, 2024, 17:04 |
Blog
Rahul Gosain: Current SoC/landscape for Follicular and Mantle Cell Lymphoma with Pallawi Torka
Rahul Gosain shared on LinkedIn: “Hematology: with Pallawi Torka we discuss the current SoC/landscape for…
Aug 14, 2024, 14:08 |
Insight
Michael Wang: Phenotype- and target-driven discovery are necessary for finding cures
Michael Wang shared on X a recent paper by Zhenyi Wang et al. titled "Innovating…
Jul 28, 2024, 14:02 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Patrick Hwu
We are excited to introduce Dr. Patrick Hwu, a leading expert in cancer immunotherapy, as…
Jul 21, 2024, 12:19 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Michael Wang
At OncoDaily, we are excited to highlight Dr. Michael Wang, a prominent researcher and clinician…
Jul 13, 2024, 21:06 |
Insight
Michael Wang: CDK9 is a promising target in MCL
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jul 1, 2024, 02:17 |
Opinion
Michael Wang: Excellent review of the actions and complex regulation of p53
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jun 29, 2024, 16:57 |
Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 20, 2024, 10:10 |
Insight
Date of improved response rates in mantle cell lymphoma patients
MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…
Jun 17, 2024, 17:03 |
Blog
Michael Wang: I presented the data from ECHO trial
Michael Wang, Professor in the Department of Lymphoma/Myeloma and in the Department of Stem Cell…
Apr 15, 2024, 16:12 |
Insight
Michael Wang: Our Phase I TRANSCEND trial demonstrated that Liso-cel results in consistently high objective response rates
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Mar 31, 2024, 23:07 |
Blog
Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
Jan 3, 2024, 18:41 |
Insight
Julie Vose: The long awaited publication from the NAMCL Project
Julie Vose shared a post on X/Twitter: ''Finally! The long awaited publication from the NAMCL Project!…
Dec 27, 2023, 13:13 |
Insight
Charles Gaulin: Safety of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma
Charles Gaulin, Lymphoma/Myeloma Fellow at MD Anderson Cancer Center, shared on LinkedIn: "At ASH23, we presented…
All:
13
Posts:
1 - 100
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube